The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis

BACKGROUND/AIM: Patients with HBV-related decompensated cirrhosis (HBV-DeCi) should be treated with potent nucleos(t)ide analogues (NA)[entecavir (ETV) or tenofovir (TDF)]. The aim was the evaluation of safety and efficacy in terms of changes in liver disease course in HBV-DeCi patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholongitas, Evangelos, Papatheodoridis, George V., Goulis, John, Vlachogiannakos, John, Karatapanis, Stylianos, Ketikoglou, John, Vasiliadis, Themistoklis, Kontos, George, Karlaftis, Anastasios, Akriviadis, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289983/
https://www.ncbi.nlm.nih.gov/pubmed/25608681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289983/
https://www.ncbi.nlm.nih.gov/pubmed/25608681

Ejemplares similares